Literature DB >> 18257907

Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.

S Khan, P C Doré, W A C Sewell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18257907     DOI: 10.1111/j.1399-3038.2007.00658.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


× No keyword cloud information.
  1 in total

Review 1.  Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.

Authors:  Ming-Chih Lin
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.